Intravesical BCG: Current results, natural history and implicants for urothelial cancer prevention
- 1 January 1992
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 50 (S16I) , 112-119
- https://doi.org/10.1002/jcb.240501322
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: A 10-Year FollowupJournal of Urology, 1992
- A Low Dose Bacillus Calmette-Guerin Regimen in Superficial Bladder Cancer Therapy: Is it Effective?Journal of Urology, 1991
- Progression of Stage T1 Bladder Tumors After Intravesical Bacillus Calmette-GuerinJournal of Urology, 1991
- Superficial Bladder Cancer Treated with Bacillus Calmette-Guerin: A Multivariate Analysis of Factors Affecting Tumor ProgressionJournal of Urology, 1989
- Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.Journal of Clinical Oncology, 1988
- An Overview of Intravesical Therapy for Superficial Bladder TumorsJournal of Urology, 1987
- Superficial bladder cancer: the primacy of grade in the development of invasive disease.Journal of Clinical Oncology, 1987
- Experience with intravesical bacillus calmette-guèrin therapy of superficial bladder tumorsUrology, 1985
- Adjuvant Chemotherapy of Superficial Transitional Cell Bladder Carcinoma:Preliminary Results of a European Organization for Research onTreatment of Cancer Randomized Trial Comparing Doxorubicin Hydrochloride, Ethoglucid and Transurethral Resection AloneJournal of Urology, 1984
- Prognostic Factors in Superficial Bladder Tumors. A Study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative GroupJournal of Urology, 1983